Author

Polona Svegl 1

1 Unive

INFLIXIMAB TROUGH LEVELS ABOVE 7 ΜG/ML IN INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB: BETTER CONTROL OF INFLAMMATION WITHOUT INCREASED RISK OF INFECTION    

David Drobne, Tina Kurent, Sasa Golob, Polona Svegl, Polona Rajar, Sara Terzic, Matic Koželj, Gregor Novak, Natasa Smrekar, Samo Plut, Alojz Smid, Nejc Sever, Luka Strniša, Jernej Brecelj, Darja Urlep, Josko Osredkar, Matjaz Homan, Rok Orel, Borut Stabuc, Ivan Ferkolj

SHORT TERM AZATHIOPRINE CO-TREATMENT DOES NOT IMPACT LONG TERM CLINICAL OUTCOME IN INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB, BUT HAS INFLIXIMAB-SPARING EFFECT

David Drobne, Tina Kurent, Sasa Golob, Polona Svegl, Polona Rajar, Jurij Hanzel, Matic Koželj, Gregor Novak, Natasa Smrekar, Ivan Ferkolj, Borut Stabuc

Item 1 - 2 / 2
1